ARTICLE
26 September 2016

Draft Guidances On Deciding When To Submit A 501(k) For A Change To An Existing Device

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
For more information, see FDA's press release announcing the updated recommendations. Comments on both guidances are due November 7, 2016.
United States Food, Drugs, Healthcare, Life Sciences

FDA recently issued two draft guidance documents to help clarify when a change in a legally marketed medical device requires a manufacturer to submit a premarket notification, or 510(k), to FDA. The first document, "Deciding When to Submit a 510(k) for a Change to an Existing Device," addresses non-software changes and, when finalized, will supersede guidance issued in 1997. The second document, "Deciding When to Submit a 510(k) for a Software Change to an Existing Device," focuses on software changes to devices, including adaptive, corrective, and perfective software modifications. Both guidance documents include guiding principles and points for manufacturers to consider when analyzing to what extent a change may affect a device's safety and effectiveness and determining whether FDA notification is required. For more information, see FDA's press release announcing the updated recommendations. Comments on both guidances are due November 7, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More